Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
15.60
-0.24 (-1.52%)
At close: Sep 16, 2026, 4:00 PM EDT
15.38
-0.22 (-1.41%)
After-hours: Sep 16, 2026, 7:30 PM EDT
Arcturus Therapeutics Holdings Employees
As of December 31, 2025, Arcturus Therapeutics Holdings had 111 total employees, including 106 full-time and 5 part-time employees. The number of employees decreased by 65 or -36.93% compared to the previous year.
Employees
111
Change (1Y)
-65
Growth (1Y)
-36.93%
Revenue / Employee
$264,577
Profits / Employee
-$840,324
Market Cap
443.40M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 111 | -65 | -36.93% | 106 | 5 |
| Dec 31, 2024 | 176 | -4 | -2.22% | 174 | 2 |
| Dec 31, 2023 | 180 | 10 | 5.88% | 180 | 0 |
| Dec 31, 2022 | 170 | -7 | -3.95% | 170 | 0 |
| Dec 31, 2021 | 177 | 59 | 50.00% | 177 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Kyverna Therapeutics | 149 |
| C4 Therapeutics | 104 |
| BridgeBio Oncology Therapeutics | 88 |
| Editas Medicine | 87 |
| Larimar Therapeutics | 71 |
| Rezolute | 68 |
| Atea Pharmaceuticals | 55 |
| Inhibikase Therapeutics | 35 |
ARCT News
- 1 day ago - Arcturus Therapeutics Holdings Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 6 days ago - Arcturus Therapeutics Holdings Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 7 days ago - Arcturus Therapeutics Holdings Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 14 days ago - Arcturus Therapeutics price target raised to $41 from $20 at Roth Capital - TheFly
- 16 days ago - Arcturus Therapeutics to Participate in Upcoming Investor Conferences - Business Wire
- 5 weeks ago - Arcturus Therapeutics Holdings Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 5 weeks ago - Arcturus Therapeutics price target lowered to $20 from $21 at Canaccord - TheFly
- 5 weeks ago - Arcturus Therapeutics Holdings Earnings Call Transcript: Q2 2026 - Transcripts